Enalapril as initial and sole treatment in severe chronic heart failure with sodium retention. 1990

I S Anand, and G S Kalra, and R Ferrari, and P L Wahi, and P C Harris, and P A Poole-Wilson
Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Five patients, who had never received any drug treatment but who had severe chronic congestive heart failure with salt and water retention, were studied before and after a single dose of enalapril (10 mg orally). Three patients continued on enalapril as monotherapy (10 mg b.d. orally) for one month. Central haemodynamics, body fluid volumes, renal function and plasma hormones were measured at rest. The initial mean right atrial pressure was 13 +/- 4 mm Hg, pulmonary wedge pressure 29 +/- 4 mm Hg and cardiac index 1.8 +/- 0.21/min/m2. Enalapril, given acutely, caused only small changes. Two patients were withdrawn after the single dose of enalapril and treated with diuretics for clinical reasons. The remaining three patients each lost more than 4 kg in weight after one month of treatment with enalapril alone. Total body exchangeable sodium and total body water were reduced but central haemodynamics were unchanged. Although enalapril was of some benefit when given alone to patients with severe congestive heart failure, all five patients were finally treated with diuretics for clinical reasons. Enalapril is not recommended as the initial and only therapy for patients with severe congestive heart failure.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001834 Body Water Fluids composed mainly of water found within the body. Water, Body
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D004656 Enalapril An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE. Enalapril Maleate,MK-421,MK421,Renitec,Renitek,MK 421,Maleate, Enalapril
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

I S Anand, and G S Kalra, and R Ferrari, and P L Wahi, and P C Harris, and P A Poole-Wilson
February 1990, Deutsche medizinische Wochenschrift (1946),
I S Anand, and G S Kalra, and R Ferrari, and P L Wahi, and P C Harris, and P A Poole-Wilson
April 1989, Cardiovascular drugs and therapy,
I S Anand, and G S Kalra, and R Ferrari, and P L Wahi, and P C Harris, and P A Poole-Wilson
January 1991, Zeitschrift fur Kardiologie,
I S Anand, and G S Kalra, and R Ferrari, and P L Wahi, and P C Harris, and P A Poole-Wilson
September 1992, European heart journal,
I S Anand, and G S Kalra, and R Ferrari, and P L Wahi, and P C Harris, and P A Poole-Wilson
October 1986, The New England journal of medicine,
I S Anand, and G S Kalra, and R Ferrari, and P L Wahi, and P C Harris, and P A Poole-Wilson
February 1992, European heart journal,
I S Anand, and G S Kalra, and R Ferrari, and P L Wahi, and P C Harris, and P A Poole-Wilson
May 1959, Journal of chronic diseases,
I S Anand, and G S Kalra, and R Ferrari, and P L Wahi, and P C Harris, and P A Poole-Wilson
January 1994, Polskie Archiwum Medycyny Wewnetrznej,
I S Anand, and G S Kalra, and R Ferrari, and P L Wahi, and P C Harris, and P A Poole-Wilson
February 1989, Archives of disease in childhood,
I S Anand, and G S Kalra, and R Ferrari, and P L Wahi, and P C Harris, and P A Poole-Wilson
February 1989, Cardiology clinics,
Copied contents to your clipboard!